Navigation Links
Large Scale Multiple Sclerosis Vaccine Trial to Be Initiated By PharmaFrontiers

It might not be long before a vaccine for multiple sclerosis is made available. Following the promising results of a multiple sclerosis vaccine trial// in a small group of patients, PharmaFrontiers, a leading pharmaceutical company is all set to test it’s vaccine on a large scale.

Multiple sclerosis is a disease in which the myelin sheath, surrounding the nerve fibers in the spinal cord and brain is destroyed. Owing to destruction of this protective sheath, the transmission of nerve impulses to the brain is affected. Approximately 2.5 million people are afflicted by the disease, every year.

The vaccine contains inactivated myelin-specific T cells, normally found in the immune system. These cells are produced in the laboratory by radiation treatment of the extracted, multiplied and processed T-lymphocytes. The cells are then re-injected back into the patient, activating the immune system. It has been known from previous trials that re-injection of the modified T-cells eliminates the damaged nerve cells.

In some cases, the immune system also attacks the normal cells, leading to complications. In view of the above drawback, the researchers have been urged to be cautious by MS experts, who point out to other vaccine trials that have been ineffective.

The new vaccine trial would compare the progress of the disease among 100 people who have already received the vaccination with the control group (not vaccinated). It is believed that if the results of the earlier study were replicated, it might even be possible to attenuate or stop the disease progress.


'"/>




Page: 1

Related medicine news :

1. The Link Between Larger Birth Weight And Cancer Risk
2. Worlds Largest Cord Blood Bank to be started in India
3. India Has The Oldest And Largest Collection Of Preserved Mosquitoes – Mosquito Museu
4. Fear Of Dengue Epidemic Looms Large: Fever Kills Five in Pakistan
5. Visualization Found To Be Largely Dependent On The Brain
6. Large Scale Study On H5N1 Conducted
7. Pre-eclampsia Pronounced With Intake of Vitamins in Large Doses
8. Large Ambulances To Handle Obese patients In Vegas
9. Heart Related Problems-The Largest Killers In Andhra Pradesh
10. Large scale culling of poultry effected at Cote dIvoire following bird flu outbreak.
11. Children’s Center to Lead Largest-Ever Study on Kidney Disease in Childre
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/7/2016)... ... 2016 , ... The medical profession is well aware that heart attacks do ... analyzing heart attacks among 138,602 people recorded a 35% higher number of heart attacks ... agree of course–no time of year is a good time for a heart attack! ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... 2016 BOC Business Brilliance Awards under the Best New Product Launch category. Gensuite’s ... achieved through user experience. , BOC Global Events & Training Group is a ...
(Date:12/7/2016)... ... December 07, 2016 , ... Maureen McLaughlin, LA.c., a certified ... Associates of Connecticut (RMACT). McLaughlin brings nearly 20 years of experience with fertility ... patients realize their family building goals. Acupuncture helps fertility patients by ...
(Date:12/7/2016)... ... December 07, 2016 , ... “Tomorrow Trump Goes To Washington”: a brief ... the presidency and to America. “Tomorrow Trump Goes To Washington” is the creation of ... can for this country. , Nancy attributes her patriotic nature to her WWII veteran ...
(Date:12/7/2016)... ... ... “Fred Rides a Train” allows readers to tag along on a special ... Train” is the creation of published author, Janet Morrison, who has been writing mostly ... "Fred, the Dog" series is her first attempt at writing for children. Janet, Fred, ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... Inc. (NASDAQ: IONS ), the leader in antisense therapeutics, ... BMO Capital Markets Prescriptions for Success Healthcare Conference on Wednesday, December ... A live webcast of the presentation will be available on the ... be available within 48 hours and will be archived for a ... , , ...
(Date:12/7/2016)... PHILADELPHIA , Dec. 7, 2016  Lannett Company, Inc. (NYSE: ... at the BMO Capital Markets 2016 Prescription for Success Healthcare Conference ... Barclay hotel in New York City . ... investors participating at the Guggenheim Securities 4 th Annual Boston ... Boston hotel. ...
(Date:12/6/2016)... 2016  Alopexx Oncology, LLC announced data from a ... protein (immunocytokine) composed of interleukin-2 and a CD20-targeting monoclonal ... B cells as Rituxan and maintains the activities of ... involved in tumor targeting, engagement of the immune system, ... of the study (abstract #95954) were presented at the ...
Breaking Medicine Technology: